Human alpha - Fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer

Breast Cancer Research and Treatment

Volumn 63, Issue 1, 2000, Pages 41-52

  Vakharia, D ^a   Mizejewski, G J ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

Alpha fetoprotein; Breast cancer; Estradiol; Estrogen receptor; Peptides

Indexed keywords

ALPHA FETOPROTEIN; ANTIESTROGEN; ANTINEOPLASTIC AGENT; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; TAMOXIFEN;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RECEPTOR BINDING; UTERUS GROWTH;

ALPHA-FETOPROTEINS; ANIMAL; BIOLOGICAL ASSAY; BREAST NEOPLASMS; ESTRADIOL; FEMALE; HUMAN; MICE; PEPTIDE FRAGMENTS; PREGNANCY; RECEPTORS, ESTROGEN; RISK FACTORS; TUMOR CELLS, CULTURED; UTERUS;

EID: 0033791037     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006484223325     Document Type: Article

References (53)

1. Alpha-fetoprotein: A review
2. Chemistry and biology of a α-fetoprotein
3. Alpha-fetoprotein as a biologic response modifier: Relevance to domain and subdomain structure
4. The phylogeny of alpha-fetoprotein in vertebrates: Survey of biochemical and physiological data
5. Estrogen-binding site of rat alpha-fetoprotein
6. Alpha-fetoprotein biosynthesis during the growth cycle of differentiated fetal rat hepatocytes in primary monolayer culture
7. The effect of alpha-fetoprotein on the growth of placental cells in vitro
8. Phenotype and function of bone marrow-derived T and non-T cells activated in vitro by alpha-fetoprotein
9. Human alpha-fetoprotein enhances epidermal growth factor proliferation activity upon porcine granulosa cells in monolayer culture
10. Synergistic action of purified α-fetoprotein and growth factors on the proliferation of porcine granulosa cells in monolayer culture
11. Alpha-fetoprotein can regulate growth in the uterus of the immature and adult ovariectomized mouse
12. Separation of the estrogen-activated growth regulatory forms of alpha-fetoprotein in mouse amniotic fluid
13. Growth inhibition of estrogen-sensitive rat mammary tumors. Effect of an alphafetoprotein-secreting hepatoma
14. Similarity between natural and recombinant human alpha-fetoprotein as inbibitors of estrogen-dependent breast cancer growth
15. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts
16. Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells
17. Estradiol-activated alpha-fetoprotein suppress the uterotropic response to estrogens
18. Studies of the intrinsic antiuterotropic activity of murine alpha-fetoprotein
19. Inhibition of estrogen-dependent breast cancer growth by a reaction product of α-fetoprotein and estradiol
20. Alpha-fetoprotein inhibits frog metamorphosis. Implications for protein motif conservation
21. Estradiol-induced changes in spectral and biologic properties of alpha-fetoprotein
22. Transformation of alpha-fetoprotein to a negative regulator of estrogen-dependent growth by ligands of the steroid/thyroid hormone receptor superfamily. 18th International Congress
23. The recombinant third domain of human alpha-fetoprotein retains the antiestrotrophic activity found in the full-length molecule
24. Ligand-free form of human alpha-fetoprotein: Evidence for the molten globule state
25. Rigidity of human alpha-fetoprotein tertiary structure is under ligand control
26. Structural properties of AFP from human cord serum: The protein molecule at low pH possesses all the properties of the molten globule
27. Alpha-fetoprotein derived synthetic peptides: Assay of an estrogen-modifying regulatory segment
28. Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk
29. Rapid assay for oestrogen receptor binding to PCB metabolites
30. Immediate ascites conversion of mammary tumors induced in NYLR/Nya mice by 7,12-dimethylbenz-[a] anthracene and urethane feeding and by forced breeding
31. Targeting of peritoneum by the small numbers of isogeneic and allogeneic ascites carcinoma cells that infiltrate or attach to peritoneum during ascites growth
32. New colorimetric cytotoxicity assay for anticancer-drug screening
33. Mapping of an assembled epitope of human hFSHβ utilizing synthetic peptides, hormone-receptor inhibition, and monoclonal antibodies
34. Rapid and sensitive sequence comparison with FASTP and FASTA
35. A canonical structure for the ligand-binding domain of nuclear receptors
36. Exploiting the basis of proline recognition by SH3 and WW domains: Design of N-substituted inhibitors
37. An alternative ligand-independent pathway for activation of steroid receptors
38. An alpha-fetoprotein-derived peptide can inhibit growth and induce cytostasis in multiple tumor types both in vitro and in vivo
39. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERα and ERβ expressed in chinese hamster ovary cells
40. Alpha-fetoprotein: The major high-affinity estrogen binder in rat uterine cytosols
41. Estrogen-binding properties of rat, mouse and man fetospecific serum proteins. Demonstration by immuno-autoradiographic methods
42. Affinity chromatography of human, rat and mouse alpha-fetoprotein on estradiolsepharose adsorbents
43. Human alpha-fetoprotein and its purification by chromatography on immobilized estrogens
44. Conformational transitions provoked by organic solvents in β-lactoglobulin: Can a molten globule like intermediate be induced by the decrease in dielectric constant
45. Vasopressin V1 and V2 receptors in diabetes mellitus
46. FKHR binds the insulin response element in insulin-like growth factor binding protein-1 promoter
47. Relation of glucose to alpha-fetoprotein in amniotic fluid
48. Maternal serum alpha-fetoprotein and diabetes mellitus
49. Cryptic epitopes on AFP induces spontaneous immune response in hepatocellular carcinoma, liver cirrhosis and hepatitis
50. Specificity and affinity of 30 monoclonal antibodies against alpha-fetoprotein
51. Epitope mapping of human alpha-fetoprotein
52. Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer
53. Alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence